Deltagen Inc. reported consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenues totaled $0.870 million. The revenues were attributable primarily to license fees associated with the provision of knockout mice and related phenotypic data pursuant to orders placed by customers under the Company's DeltaOneTM program.

Net income before provision for income taxes for the year ended December 31, 2014 was $0.156 million.